medigraphic.com
ISSN 0210-5187 (Electronic)

2008, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2008; 36 (1)

Merkel cell tumour: a clinical, histological, inmunochemical and microscopic study

García-Salces I, Cortázar VJ, Sánchez SP, Pérez PJ, Agurruza IJM, Grasa JM, Lázaro J, Carapeto FJ

Language: Spanish
References: 25
Page: 13-17
PDF size: 249.66 Kb.


ABSTRACT

Merkel cell carcinoma is an inusual and aggressive primary cutaneous tumor with neuroendocrine features. Several etiological factors have been proposed specially ultraviolet radiation exposition. Although its clinical presentation and characteristic histology are usually enough, immunochemistry features are very helpful to make an accuracy diagnosis. Because of its agressive behaviour and bad outcome there are not standard therapeutic procedures established nowadays. We present a case of a patient with a Merkel cell carcinoma in right lower limb. Sentinel lymph node procedure was positive. We make a revision of diagnostic and therapeutic procedures used currently


REFERENCES

  1. 1.Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005;89:1-4.

  2. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and diferences. Cancer Epidemiol Biomarkers Prev 1999;8:153-158.

  3. Penn I, First MR. Merkel´s cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999;68:1717-1721.

  4. Llombart B, Monteagudo C, López-Guerrero JA, Carda C, Jorda E, Sanmartin O, Almenar S, Molina I, Martin JM, Llombart-Bosch A. Clinicopathological and inmunohistochemical analysis of 20 cases os Merkel cell carcinoma in search of prognostic markers. Histopathology 2005;46:622-634.

  5. 5.Brenner B, Sulkes A, Rakowsky E, Feinmesser M, Yukelson A, Bar-Haim E, Katz A, Idelevich E, Neuman A, Barhana M, Fenig E. Second neoplasms in patients with Merkel cell carcinoma. Cancer 2001;91:1358-1362.

  6. 6.Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S, Cocquyt V, Bridge J, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D, Speleman F. Mutation analysis of p73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000;82:823-826.

  7. 7.Rodríguez-Costa J, Rodríguez-Paternina E, Muñoz-Aguilera R. Metastasis de un carcinoma de células de Merkel en un paciente con trasplante cardíaco, diagnosticado mediante PAAF. Patología 1996;29:255-258.

  8. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet 2002;359:497-498.

  9. 9.Lien HC, Tsai TF, Lee YY, Hsiao CH. Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol 1999;41:641-643.

  10. Hitchcock CL, Bland KI, Laney RG 3d, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis and treatment. Ann Surg 1988;207:201-207.

  11. Junquera L, Torre A, Vicente JC, García-Consuegra L, Fresno MF. Complete spontaneous regression of Merkel cell carcinoma. Ann Otol Rhinol Laryngol 2005;114:376-380.

  12. 12.Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas os various sites. Am J Surg Pathol 1990;12:7-16.

  13. 13.Mount SL, Taatjes DJ. Neuroendocrine carcinoma of the skin (Merkel cell carcinoma). An immunoelectron-microscopic case study. Am J Dermatopathol 1994;16:60-65.

  14. Su LD, Lowe L, Bradford CR, et al. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002;46:661-666.

  15. 15.Bickle K, Glass F, Messina JL, Fenske NA, Siegrist K. Merkel cell carcinoma: a clinical, histopathologic and immunohistochemical review. Semin Cutan Med Surg 2004;23:46-53.

  16. 16.Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 1995;21:669-683.

  17. 17.Wick MR, Goellner JR, Scheithauer BW, Thomas JR 3rd, Sánchez NP, Schroeter AL. Primary neuroendocrine carcinomas of the skin (Merkel cell tumors). A clinical, histologic and ultrastructural study of thirteen cases. Am J clin Pathol 1983;79:6-13.

  18. 18.Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH. Merkel cell carcinoma: analysis of clinical, histologic and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997;37:734-739.

  19. 19.Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment os patients from a single institution. J Clin Oncol 2005;23:2300-2309.

  20. 20.Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.

  21. Marks ME, Kim RY, Salter MM. Radiotherapy as an adjunct in the management of Merkel cell carcinoma. Cancer 1990;65:60-64.

  22. 22.Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881-885.

  23. 23.Fernández-Figueras MT, Puig L, Musulen E, Gilaberte M, Ferrándiz C, Lerma E, Ariza A. Prognosis significance of p27kip1, p45skp2 and ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma and cutaneous squamous cell carcinoma. Histopathology 2005;46:614-621.

  24. 24.Bertó J, Cuenca A, Díaz-Martínez B, Peña ML, Ruíz-Fernández P, Sánchez de Paz F. Carcinoma de células de Merkel. Estudio de cinco casos. Actas Dermosifiliogr 2005;96:106-110.

  25. 25.Sais G, Armella C, Soler T. Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Venereol 2002;16:82-83.




2020     |     www.medigraphic.com